61 results
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
containing any Hazardous Material), including the movement of any Hazardous Material through the air, soil, surface water or groundwater
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
Material through the air, soil, surface water or groundwater.
“Requirements of Law” means, with respect to any Person, collectively, the common law
8-K
EX-10.1
ruyfk
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-2.1
og6tgb5gs90 8s0
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-10.2
bn7s7l739doj
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
gp49otppgptniomg7 rn
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
S-3ASR
EX-1.2
72kkx2hp4 z5yae
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-1.1
y1nguvs2tyz10d09my
16 Feb 21
Entry into a Material Definitive Agreement
8:35am
8-K
EX-1.1
dys v6b8pdj
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-1.1
i1wowvwlzj3860k5p
13 Nov 20
Entry into a Material Definitive Agreement
12:00am